European startup investment dropped sharply in October, with companies pulling in just €6 billion across 288 funding rounds. That marks a 62 percent slide from September’s €15.8 billion haul, even though deal count barely moved.
The pullback follows an unusually strong September, when mega-rounds inflated totals well beyond typical monthly averages. October’s numbers signal a return to the more cautious pace that has defined much of 2026. Investors continue writing checks, but the enormous nine-figure deals have grown scarce.
British AI chipmaker Fractile landed the month’s biggest round. Filings with Companies House show the company secured approximately £577 million in Series C financing to advance its AI inference chip development. Nine other startups raised more than €100 million each. Meanwhile, 42 deals closed without disclosing financial terms.
Healthtech dominated sector rankings, capturing 21.8 percent of all October investment at €5.2 billion. No other vertical came close to matching that concentration of capital.
The United Kingdom held its position as Europe’s top fundraising market, generating €2.6 billion across 75 transactions. That result extends a long-running pattern of British dominance in European venture activity.
Exit volume stayed flat. October recorded 39 transactions, identical to September’s total. The steady pace suggests founders and acquirers have settled into a predictable rhythm, neither rushing for the exits nor holding back entirely.
Looking ahead, the gap between deal volume and total value points to a market still willing to fund early-stage companies while remaining selective about larger growth rounds. Whether November reverses October’s decline depends heavily on whether any blockbuster deals emerge before year-end.
